🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Washington

Uji klinis Kanker (semua jenis) di Washington

58 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Washington.

Kota di Washington

Teks studi resmi (Bahasa Inggris)

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • Fred Hutchinson Cancer Center. /ID# 277939, Seattle
  • Northwest Cancer Specialists - Vancouver /ID# 277855, Vancouver
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07155187

Registry Study for Radiation Therapy Outcomes

  • University of Washington, Seattle
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT01255748

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Swedish Cancer Institute, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06150157

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Seattle Children's Hospital, Seattle
Menerima peserta
Usia 15 hingga 24 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07223463

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

  • Fred Hutchinson Cancer Center ( Site 0106), Seattle
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07405164

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Northwest Medical Specialties, Bonney Lake
  • Northwest Medical Specialties, Federal Way
  • Northwest Medical Specialties, Gig Harbor
  • dan 4 lainnya
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 2/3
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

  • Fred Hutchinson, Seattle
Menerima pesertaStudi observasional
2 Months · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00900198

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Seattle Neuropsychiatric Treatment Center, Seattle
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06953960

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  • Investigational Site Number: 400, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05997615

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Swedish Cancer Institute - Edmonds, Edmonds
  • Kadlec Clinic Hematology and Oncology, Kennewick
  • Swedish Medical Center, Seattle
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

  • Cancer Care Northwest, Spokane
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07169851

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • University of Washington, Seattle
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06163534

Prostate Active Surveillance Study

  • Veterans Affairs Puget Sound Health Care System, Seattle
  • University of Washington, Seattle
Menerima pesertaStudi observasional
Usia 21 ke atas · Pria · Diperbarui 2 Sep 2026 · NCT00756665

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Cancer Care Northwest-1 (601 S. Sherman), Spokane
  • Cancer Care Northwest_2 (605 E. Holland), Spokane
  • Cancer Care Northwest, Spokane Valley
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06072612

A Study of ARC-02 in B-cell NHL

  • Summit Cancer Centers - North Spokane, Spokane
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07691606

Project: Every Child for Younger Patients With Cancer

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • dan 1 lainnya
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04515810

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 10 Agu 2026 · NCT06067841

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • Seattle Children's Hospital Research Foundation, Seattle
Menerima pesertaFase 2
Usia 1 hingga 39 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • dan 20 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07680439

Resilience Mobile App for Teens and Young Adults With Cancer

  • Seattle Children's Hospital, Seattle
Menerima peserta
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT05842902

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • Swedish Cancer Institute, Edmonds
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05719558

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Fred Hutchinson Cancer Center. /ID# 267940, Seattle
  • Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Fred Hutchinson Cancer Research Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06162221

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

  • GSK Investigational Site, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06431594

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844

Childhood Cancer Survivor Study

  • Seattle Children's Hospital, Seattle
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT03686124

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.